natgillin/translations-raw huggingface dataset:
The European Commission granted a marketing authorisation valid throughout the EU for Letifend on 20.04.2016. 
Evropska komisija je dovoljenje za promet z zdravilom Letifend, veljavno po vsej Evropski uniji, izdala 20. aprila 2016.
In the future, if the animals are exposed to the parasite, the immune system will be able to respond more quickly. 
Ob ponovni izpostavitvi živali parazitu v prihodnosti se bo imunski sistem tako hitreje odzval.
Letifend is a vaccine. 
Zdravilo Letifend je cepivo.
In a field study in France and Spain 275 dogs were vaccinated with Letifend and 274 dogs received placebo (a dummy vaccination). 
V terenski študiji v Franciji in Španiji je bilo 275 psov cepljenih z zdravilom Letifend, 274 psov pa je prejelo placebo (cepivo brez zdravilne učinkovine).
The most common side effect with Letifend (which may affect more than 1 in 10 animals) is scratching at the injection site which resolves within four hours. 
Najpogostejši neželeni učinek zdravila Letifend (ki lahko prizadene več kot 1 od 10 živali), je praskanje na mestu injiciranja, ki izgine v štirih urah.
The Agency's Committee for Medicinal Products for Veterinary Use (CVMP) concluded that Letifend's benefits are greater than its risks and recommended that it be approved for use in the EU. 
Odbor za zdravila za uporabo v veterinarski medicini (CVMP) pri agenciji je zaključil, da so koristi zdravila Letifend večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
The parasite is widespread in countries bordering the Mediterranean Sea and is transmitted by the bites of sand flies. 
Ta parazit je razširjen v deželah ob Sredozemskem morju in se prenaša s pikom peščenih muh.
The vaccine is given to dogs from 6 months of age as a single injection under the skin. 
Cepivo se daje psom, starejšim od šestih mesecev, kot ena injekcija pod kožo.
Dogs that have been infected may show no signs of infection, but some have active disease with symptoms such as fever, hair and weight loss, and skin sores. 
Okuženi psi morda ne bodo kazali znakov okužbe, pri nekaterih pa se razvije aktivna bolezen s simptomi, kot so zvišana temperatura, izpadanje dlake in izguba telesne mase ter rane na koži.
What is Letifend and what is it used for? 
Kaj je zdravilo Letifend in za kaj se uporablja?
Over a two year period there were 8 confirmed cases of leishmaniasis in the vaccinated group compared with 19 cases in the placebo group, showing that Letifend was effective in reducing the occurrence of the disease. 
V dveh letih so potrdili 8 primerov leishmanioze v skupini, ki je prejela cepivo, v primerjavi z 19 primeri v skupini, ki je prejela placebo, kar je dokazalo, da je zdravilo Letifend učinkovito pri zmanjševanju pojavnosti bolezni.
What benefits of Letifend have been shown in studies? 
Kakšne koristi je zdravilo Letifend izkazalo v študijah?
Why is Letifend approved? 
Zakaj je bilo zdravilo Letifend odobreno?
Only non-infected animals should be vaccinated. 
Cepite le neokužene živali.
What are the risks associated with Letifend? 
Kakšna tveganja so povezana z zdravilom Letifend?
Letifend is available as a freeze-dried powder (lyophilisate) and solvent that are made up into a solution for injection, and can only be obtained with a prescription. 
Zdravilo Letifend je na voljo v obliki praška, sušenega z zamrzovanjem (liofilizata) in vehikla za pripravo raztopine za injiciranje, njegova izdaja pa je le na recept.
Infected dogs can help spread the disease to humans. 
Z okuženih psov se bolezen lahko prenese tudi na človeka.
Protection starts four weeks after vaccination and lasts one year. 
po cepljenju in traja eno leto.
Letifend contains the active substance protein Q, which is made of different fragments of proteins from Leishmania infantum. 
Zdravilo Letifend vsebuje zdravilno učinkovino protein Q, narejeno iz različnih fragmentov proteinov parazita Leishmania infantum.
The dogs were exposed to natural infection with Leishmania infantum. 
Psi so bili izpostavljeni naravni okužbi s parazitom Leishmania infantum.
Other information about Letifend? 
Druge informacije o zdravilu Letifend
Letifend canine leishmaniasis vaccine (recombinant protein) 
Letifend cepivo za pse proti leishmaniozi (rekombinantni protein)
For practical information about using Letifend, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist. 
Za praktične informacije o uporabi zdravila Letifend naj lastniki ali skrbniki živali preberejo navodilo za uporabo ali se posvetujejo z veterinarjem ali farmacevtom.
For more information about treatment with Letifend, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist. 
Za več informacij o zdravljenju z zdravilom Letifend naj lastniki ali skrbniki živali preberejo navodilo za uporabo ali se posvetujejo z veterinarjem ali farmacevtom.
Letifend is a veterinary vaccine used in dogs to protect them against leishmaniasis due to the parasite Leishmania infantum. 
Letifend je cepivo za uporabo v veterinarski medicini, ki se uporablja za zaščito psov pred leishmaniozo, ki jo povzroča parazit Leishmania infantum.
When Letifend is given to dogs the immune system recognises the Leishmania protein as ‘foreign' and makes defences against it. 
Ko pes prejme zdravilo Letifend, imunski sistem prepozna protein parazita Leishmania kot tujek in proti njemu tvori protitelesa.
How does Letifend work? 
Kako zdravilo Letifend deluje?
Before vaccination, dogs should be tested for Leishmania infection. 
Pred cepljenjem je treba pse testirati na okužbo s parazitom Leishmania.
A ‘booster' injection should be given every year to maintain the vaccine's effect. 
Za vzdrževanje učinka cepiva je treba nato vsako leto psu injicirati obnovitveni odmerek.
How is Letifend used? 
Kako se zdravilo Letifend uporablja?
vaccinated dogs since the vaccine does not prevent Leishmania infection. 
Pri cepljenih psih je treba upoštevati ukrepe za zmanjšanje izpostavljenosti peščenim muham, saj cepivo ne preprečuje okužbe s parazitom Leishmania.
3 years. 
3 mesece.
PHARMACEUTICAL FORM AND CONTENTS 28 tablets 
FARMACEVTSKA OBLIKA IN VSEBINA 28 tablet
Frequencies are defined as very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1,000 to <1/100), rare (≥1/10,000 to <1/1,000), very rare (<1/10,000) and not known (cannot be estimated from available data). 
Pogostnost je opredeljena kot zelo pogosti (≥ 1/10), pogosti (≥ 1/100 do < 1/10), občasni (≥ 1/1.000 do < 1/100), redki (≥ 1/10.000 do < 1/1.000), zelo redki (< 1/10.000) in neznana (ni mogoče oceniti iz razpoložljivih podatkov).
84 tablets 
84 tablet
Headache Mild or moderate severity headache was reported in 5.8% of patients. 
O blagem ali zmernem glavobolu so poročali pri 5,8 % bolnic.
Patients with controlled bleedingb,c, d 
Bolnice z nadzorovano krvavitvijob,c,d
The observed frequency is in line with control groups and prevalence reported in literature for symptomatic pre-menopausal women of this age group (mean of 40 years). 
Opažena pogostost je bila skladna s kontrolnimi skupinami in prevalenco, o kateri poročajo v literaturi, pri simptomatskih ženskah pred menopavzo v tej starostni skupini (povprečno 40 let).
EU/1/18/1309/001 28 tablets EU/1/18/1309/002 84 tablets EU/1/18/1309/003 30 tablets EU/1/18/1309/004 28 tablets EU/1/18/1309/005 84 tablets 
EU/1/18/1309/001 28 tablet EU/1/18/1309/002 84 tablet EU/1/18/1309/003 30 tablet EU/1/18/1309/004 28 tablet EU/1/18/1309/005 84 tablet
If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. 
Nosečnost in dojenje Če ste noseči ali dojite, menite, da bi lahko bili noseči ali načrtujete zanositev, se posvetujte z zdravnikom ali farmacevtom, preden vzamete to zdravilo.
17, rue de Pontoise F-95520 Osny France 
17 rue de Pontoise F-95520 Osny Francija
Patients in amenorrheab,c 
Bolnice z amenorejob,c
The MAH shall perform the required pharmacovigilance activities and interventions detailed in the agreed RMP presented in Module 1.8.2. of the Marketing Authorisation and any agreed subsequent updates of the RMP. 
• Načrt za obvladovanje tveganja (RMP) Imetnik dovoljenja za promet z zdravilom bo izvedel zahtevane farmakovigilančne aktivnosti in ukrepe, podrobno opisane v sprejetem RMP, predloženem v modulu 1.8.2 dovoljenja za promet z zdravilom, in vseh nadaljnjih sprejetih posodobitvah RMP.
Treatment whilst pregnant might affect your pregnancy (it is not known if Ulipristal Acetate Gedeon Richter might harm your baby or whether can cause miscarriage). 
Zdravljenje med nosečnostjo lahko vpliva na nosečnost (ni znano, ali zdravilo Ulipristal Acetate Gedeon Richter lahko škoduje vašemu otroku ali morda lahko pride do spontanega splava).
If you forget to take Ulipristal Acetate Gedeon Richter If you miss a dose by less than 12 hours, take it as soon as you remember. 
Če ste pozabili vzeti zdravilo Ulipristal Acetate Gedeon Richter Če za manj kot 12 ur pozabite vzeti odmerek, ga vzemite takoj, ko se spomnite.
Gedeon Richter (listed in section 6). 
Richter, (navedeno v poglavju 6);
clarithromycin, erythromycin, rifabutin). 
eritromicin, rifabutin),
Tell your doctor or pharmacist if you are taking any of the medicines listed below, as these medicines can affect Ulipristal Acetate Gedeon Richter or be affected by Ulipristal Acetate Gedeon Richter: - Certain medicines which are used to treat the heart (e.g. digoxin). 
Povejte zdravniku ali farmacevtu, če jemljete katero koli od spodaj navedenih zdravil, saj ta zdravila lahko vplivajo na zdravilo Ulipristal Acetate Gedeon Richter, ali pa zdravilo Ulipristal Acetate Gedeon Richter vpliva nanje: - nekatera zdravila za zdravljenje bolezni srca (npr. digoksin),
Ulipristal Acetate Gedeon Richter should not be taken by children under 18 years of age since safety and efficacy of ulipristal acetate has not been established in this age group. 
Otroci in mladostniki Otroci, mlajši od 18 let, zdravila Ulipristal Acetate Gedeon Richter ne smejo jemati, saj varnost in učinkovitost ulipristalacetata v tej starostni skupini nista dokazani.
In vitro data indicate that ulipristal acetate and its active metabolite do not inhibit CYP1A2, 2A6, 2C9, 2C19, 2D6, 2E1, and 3A4, or induce CYP1A2 at clinically relevant concentrations. 
Podatki in vitro kažejo, da ulipristalacetat in njegovi aktivni presnovki pri klinično pomembnih koncentracijah ne zavirajo encimov CYP1A2, 2A6, 2C9, 2C19, 2D6, 2E1 in 3A4 ali inducirajo
* see section "Description of selected adverse reactions" ** The verbatim term “mild hair loss” was coded to the term “alopecia” 
** Dobesedni izraz blaga izguba las se je razvrstil kot izraz »alopecija«.
Patients starting treatment course 2 or 4 
Bolnice, ki so začele 2. ali 4.
- If you have liver or kidney disease tell your doctor or pharmacist before taking Ulipristal Acetate Gedeon Richter. 
- če imate bolezen jeter ali ledvic, povejte svojemu zdravniku ali farmacevtu preden vzamete zdravilo Ulipristal Acetate Gedeon Richter;
Do not take Ulipristal Acetate Gedeon Richter - if you are allergic to ulipristal acetate or any of the other ingredients of Ulipristal Acetate 
Ne jemljite zdravila Ulipristal Acetate Gedeon Richter - če ste alergični na ulipristalacetat ali katero koli sestavino zdravila Ulipristal Acetate Gedeon
Renal impairment is not expected to significantly alter the elimination of ulipristal acetate. 
Ledvična okvara Ni pričakovati, da bi ledvična okvara bistveno spremenila izločanje ulipristalacetata.
Do not take Ulipristal Acetate Gedeon Richter if you are pregnant. 
Ne jemljite zdravila Ulipristal Acetate Gedeon Richter, če ste noseči.
THE TABLE BELOW HELPS YOU TO TRACK YOUR BLOOD TESTS: 
SPODNJA PREGLEDNICA SLUŽI KOT POMOČ PRI SPREMLJANJU KRVNIH
Ulipristal Acetate Gedeon Richter is used in adult women (over 18 years of age) before they reach the menopause. 
Zdravilo Ulipristal Acetate Gedeon Richter se uporablja pri odraslih ženskah (starejših od 18 let), ki še niso v menopavzi.
Depending on the result of these tests, the doctor will decide if treatment with Ulipristal Acetate Gedeon Richter is suitable for you. 
Glede na rezultate teh preiskav bo zdravnik odločil, ali je zdravljenje z zdravilom Ulipristal Acetate Gedeon Richter za vas primerno.
In vitro data indicate that ulipristal acetate and its active metabolite are not P-gp (ABCB1) substrates. 
Podatki in vitro kažejo, da ulipristalacetat in njegov aktivni presnovek nista substrata P-gp (ABCB1) Posebne skupine bolnikov
Ulipristal Acetate Gedeon Richter is likely to make some hormonal contraceptives less effective (see “Other medicines and Ulipristal Acetate Gedeon Richter”). 
Zdravilo Ulipristal Acetate Gedeon Richter lahko zmanjša učinkovitost nekaterih hormonskih kontracepcijskih sredstev (glejte poglavje »Druga zdravila in zdravilo Ulipristal Acetate Gedeon Richter«).
If you do become pregnant during Ulipristal Acetate Gedeon Richter treatment, you should stop taking Ulipristal Acetate Gedeon Richter immediately and contact your doctor or pharmacist. 
Če med zdravljenjem z zdravilom Ulipristal Acetate Gedeon Richter zanosite, morate takoj prenehati jemati zdravilo Ulipristal Acetate Gedeon Richter in obvestiti svojega zdravnika ali farmacevta.
Use in women with severe asthma insufficiently controlled by oral glucocorticoids is not recommended. 
Bolnice z astmo Za ženske s hudo obliko astme, ki je neustrezno nadzorovana s peroralnimi glukokortikoidi, uporaba zdravila ni priporočljiva.
• inform the patients about potential adverse reactions related to liver that could be caused by the use of Ulipristal Acetate Gedeon Richter. 
• bolnice obvestite o možnih neželenih učinkih, povezanih z jetri, ki jih lahko povzroči jemanje zdravila Ulipristal Acetate Gedeon Richter.
- If you are currently taking hormonal contraception (for example birth control pills) (see “Other medicines and Ulipristal Acetate Gedeon Richter”) you should use an alternative reliable barrier contraceptive method (such as a condom) while taking Ulipristal Acetate Gedeon Richter. 
- če trenutno jemljete hormonska kontracepcijska sredstva (na primer kontracepcijske tablete) (glejte poglavje »Druga zdravila in zdravilo Ulipristal Acetate Gedeon Richter«), morate med jemanjem zdravila Ulipristal Acetate Gedeon Richter uporabljati drugo zanesljivo pregradno kontracepcijsko metodo (na primer kondom);
There is no relevant use of ulipristal acetate in the paediatric population. 
Pediatrična populacija Ulipristalacetat ni primeren za uporabo pri pediatrični populaciji.
A majority of women taking a therapeutic dose of ulipristal acetate have anovulation, however, the level of fertility while taking multiple doses of ulipristal acetate has not been studied. 
Plodnost Pri večini žensk, ki jemljejo terapevtske odmerke ulipristalacetata, se pojavi anovulacija, vendar stopnje plodnosti pri jemanju večkratnih odmerkov ulipristalacetata niso raziskovali.
What Ulipristal Acetate Gedeon Richter is and what it is used for What you need to know before you take Ulipristal Acetate Gedeon Richter How to take Ulipristal Acetate Gedeon Richter Possible side effects 
Kaj je zdravilo Ulipristal Acetate Gedeon Richter in za kaj ga uporabljamo Kaj morate vedeti, preden boste vzeli zdravilo Ulipristal Acetate Gedeon Richter Kako jemati zdravilo Ulipristal Acetate Gedeon Richter
If you stop taking Ulipristal Acetate Gedeon Richter Ulipristal Acetate Gedeon Richter is to be taken daily during treatment courses of up to 3 months continuously. 
Če ste prenehali jemati zdravilo Ulipristal Acetate Gedeon Richter Zdravilo Ulipristal Acetate Gedeon Richter je treba jemati neprekinjeno vsak dan v času cikla zdravljenja, ki traja po največ 3 mesece.
Ulipristal acetate may have minor influence on the ability to drive or use machines as mild dizziness has been observed after ulipristal acetate intake. 
4.7 Vpliv na sposobnost vožnje in upravljanja strojev Ulipristalacetat ima lahko manjši vpliv na sposobnost vožnje ali upravljanja strojev, saj so pri zaužitju ulipristalacetata opazili blago omotico.
During each course of treatment, do not stop taking your tablets without the advice of your doctor even if you feel better, as symptoms may re-occur later. 
če vam tako ne naroči zdravnik, tudi če se počutite bolje, saj se simptomi lahko pozneje pojavijo znova.
Your period should generally return within 4 weeks after treatment with Ulipristal Acetate Gedeon Richter is stopped. 
Mesečno perilo se ponavadi povrne v 4 tednih po prekinitvi zdravljenja z zdravilom Ulipristal Acetate Gedeon Richter.
This card provides information on blood tests you will need throughout treatment and on what you should do if liver side effects occur. 
Ta kartica vsebuje informacije o krvnih preiskavah, ki jih boste opravili tekom zdravljenja, in o tem,
Treatment with Ulipristal Acetate Gedeon Richter usually leads to a significant reduction or may even stop your menstrual bleeding (your ‘period') within the first 10 days of treatment. 
Zdravljenje z zdravilom Ulipristal Acetate Gedeon Richter ponavadi v prvih 10 dneh zdravljenja bistveno zmanjša menstrualne krvavitve (mesečno perilo) ali jih lahko celo ustavi.
Ulipristal Acetate Gedeon Richter is likely to make some hormonal contraceptives less effective. 
Zdravilo Ulipristal Acetate Gedeon Richter lahko zmanjša učinkovitost nekaterih hormonskih kontracepcijskih sredstev.
PHARMACEUTICAL PARTICULARS 6.1 List of excipients Microcrystalline cellulose 
FARMACEVTSKI PODATKI 6.1 Seznam pomožnih snovi mikrokristalna celuloza manitol premreženi natrijev karmelozat smukec magnezijev stearat
- Certain medicines used to treat epilepsy (e.g. phenytoin, fosphenytoin, phenobarbital, 
- nekatera zdravila za zdravljenje epilepsije (npr. fenitoin, fosfenitoin, fenobarbital,
Before you start treatment with Ulipristal Acetate Gedeon Richter blood tests will be undertaken to find out how well your liver is working. 
- pred uvedbo zdravljenja z zdravilom Ulipristal Acetate Gedeon Richter, boste opravili preiskave krvi, da se ugotovi, kako dobro delujejo vaša jetra.
Ulipristal Acetate Gedeon Richter treatment is to be initiated and supervised by physicians experienced in the diagnosis and treatment of uterine fibroids. 
Zdravljenje z zdravilom Ulipristal Acetate Gedeon Richter morajo uvesti in nadzorovati zdravniki, z izkušnjami pri diagnosticiranju in zdravljenju materničnih leiomiomov.
If during the treatment you experience any liver related signs such as feeling of being sick (nausea or vomiting), fatigue, severe tiredness, jaundice (yellowing of the eyes or skin), dark urine, itching or upper stomach ache, you should stop treatment and immediately contact a doctor, who will check the functioning of your liver and decide if you can continue the treatment. 
(siljenje na bruhanje) ali bruhanje, utrujenost, huda utrujenost, zlatenica (porumenelost oči ali kože), temen urin, srbenje ali bolečina v zgornjem delu trebuha, morate o tem takoj obvestiti zdravnika, ki bo preveril delovanje vaših jeter in se odločil, ali boste z zdravljenjem nadaljevali.
breast discomfort - swelling due to fluid retention (oedema) - extreme tiredness (asthenia) - increase in blood cholesterol seen in blood tests, increase in blood fats (triglycerides) seen in blood tests. 
- izjemna utrujenost (astenija), - povišanje ravni holesterola v krvi pri krvnih preiskavah, povišanje maščob (trigliceridov) v krvi pri krvnih preiskavah.
• key effects of Ulipristal Acetate Gedeon Richter on Progesterone Receptor Modulator Associated Endometrial Changes (PAEC) and how they differ from those of unopposed oestrogen. 
• ključni učinki zdravila Ulipristal Acetate Gedeon Richter na spremembe endometrija, povezane z modulatorji progesteronskih receptorjev (PAEC- Progesterone Receptor
You should nonetheless ask your doctor or pharmacist for advice if you take more Ulipristal Acetate Gedeon Richter than you should. 
Kljub temu pa se posvetujte s svojim zdravnikom ali farmacevtom, če ste vzeli večji odmerek zdravila Ulipristal Acetate Gedeon Richter, kot bi smeli.
Ulipristal Acetate Gedeon Richter is contraindicated in patients with hepatic disorder (see section 4.3 and 4.4). 
Gedeon Richter je kontraindicirano pri bolnicah z jetrno boleznijo (glejte poglavji 4.3 in 4.4).
During treatment with Ulipristal Acetate Gedeon Richter, your doctor will carry out regular blood tests to check your liver function. 
Med zdravljenjem z zdravilom Ulipristal Acetate Gedeon Richter boste po navodilu zdravnika opravljali redne krvne preiskave za preverjanje delovanja jeter.
Mechanism of action Ulipristal acetate exerts a direct effect on the endometrium. 
Ulipristalacetat ima neposreden učinek na endometrij.
In all Phase III studies including repeated intermittent treatment studies, a total of 7 cases of hyperplasia were observed out of 789 patients with adequate biopsies (0.89%). 
789 bolnicami, pri katerih so opravili ustrezno biopsijo (0,89 %), opazili skupno 7 primerov hiperplazije.
If, during repeated intermittent treatment, after the initial reduction in bleeding or amenorrhea, an altered persistent or unexpected bleeding pattern occurs, such as inter-menstrual bleeding, investigation of the endometrium including endometrial biopsy should be performed in order to exclude other underlying conditions, including endometrial malignancy. 
Če se med ponavljajočim se intermitentnim zdravljenjem po začetnem zmanjšanju krvavitev ali amenoreji pojavi trajno spremenjen ali nepričakovan vzorec krvavitev, kot so vmesne krvavitve, bo morda potreben pregled endometrija, vključno z biopsijo, za izključitev drugih bolezni, tudi malignih sprememb endometrija.
Ulipristal acetate is indicated for one treatment course of pre-operative treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age. 
4.1 Terapevtske indikacije Ulipristalacetat je indiciran za en cikel predoperacijskega zdravljenja zmernih do hudih simptomov materničnih leiomiomov pri odraslih ženskah v rodni dobi.
Therefore, hormonal contraceptives are not recommended and you should use an alternative reliable barrier contraceptive method, such as a condom, during Ulipristal Acetate Gedeon Richter treatment. 
Zato uporaba hormonskih kontracepcijskih sredstev ni priporočljiva in morate med zdravljenjem z zdravilom Ulipristal Acetate Gedeon Richter uporabiti drugo zanesljivo pregradno kontracepcijsko metodo, kot je kondom.
- Certain medicines to treat fungal infections (e.g. ketoconazole (except shampoo), itraconazole). 
- nekatera zdravila za zdravljenje glivičnih okužb (npr. ketokonazol (razen v obliki šampona),
Study 2 contained the active comparator, leuprorelin 3.75 mg given once per month by intramuscular injection. 
levprorelin, 3,75 mg enkrat na mesec v obliki intramuskularnega injiciranja.
What Ulipristal Acetate Gedeon Richter is and what it is used for 
Kaj je zdravilo Ulipristal Acetate Gedeon Richter in za kaj ga uporabljamo
You should always start taking Ulipristal Acetate Gedeon Richter within the first week of your menstrual period. 
Zdravilo Ulipristal Acetate Gedeon Richter vedno začnite jemati v prvem tednu menstruacije.
INFORMATION IN BRAILLE Ulipristal Acetate Gedeon Richter 
PODATKI V BRAILLOVI PISAVI Ulipristal Acetate Gedeon Richter
What Ulipristal Acetate Gedeon Richter looks like and contents of the pack Ulipristal Acetate Gedeon Richter is white to off-white, round curved tablet of 7 mm engraved with code “ES5” on one face. 
Zdravilo Ulipristal Acetate Gedeon Richter je bela do umazano bela okrogla izbočena tableta s premerom 7 mm, z vtisnjenim napisom »ES5« na eni strani.
• inform the patients not to take Ulipristal Acetate Gedeon Richter in case of liver problems. 
• bolnice opozorite, da ne smejo jemati zdravila Ulipristal Acetate Gedeon Richter, če imajo težave z jetri.
- Certain medicines used to prevent strokes and blood clots (e.g. dabigatran etexilate). 
- nekatera zdravila za preprečevanje možganske kapi in krvnih strdkov (npr. dabigatraneteksilat),
Ulipristal Acetate Gedeon Richter passes into the breast milk. 
Zdravilo Ulipristal Acetate Gedeon Richter prehaja v materino mleko.